Fine, Richard E.
Gilmore, Richard C.
Dietz, Jill R.
Boolbol, Susan K.
Berry, Michael P.
Han, Linda K.
Kenler, Andrew S.
Sabel, Michael
Tomkovich, Kenneth R.
VanderWalde, Noam A.
Chen, Margaret
Columbus, Karen S.
Curcio, Lisa D.
Feldman, Sheldon M.
Gold, Linsey
Hernandez, Lydia
Manahan, Eric R.
Seedman, Susan A.
Vaidya, Rashmi P.
Sevrukov, Alexander B.
Aoun, Hussein D.
Hicks, Randy D.
Simmons, Rache M.
Article History
First Online: 16 August 2021
Disclosures
: Andrew S. Kenler: I was the medical Director of Icecure for approximately 5 years and during the time period of this study and was paid for my time as medical Director. That relationship ended approximately 1 year ago. Kenneth R. Tomkovich: Stipend received for data entry for patients enrolled in trial to CentraState medical center by IceCure medical. Probes and cryoablation unit provided by IceCure medical to conduct the trial. I received no personal funds for conducting the trial or for the preparation of this manuscript. Neither I nor my medical institution have any relevant conflict of interest in conducting this research. Richard E. Fine: West Cancer Center and Research Institute (Author's institution) received financial support for conducting the clinical trial. Served on the original scientific advisory board that participated in the Ice3 trial protocol design. Expenses were reimbursed for travel to Chicago, IL, in 2014. Margaret Chen-Seetoo: Novian Health - research grant. Theraclion - research grant. Agendia - research grant. PreludeDx - research grant. Susan A. Seedman: Profited $280 from prior purchase and sale of publicly traded stock.